Pharmacyte Biotech Inc., of Laguna Hills, Calif., said recent research at the Ann and Robert H. Lurie Children's Hospital of Chicago and Northwestern University's Feinberg School of Medicine published in Child's Nervous System further support the company's efforts to develop a targeted cannabinoid-based chemotherapy for brain cancer utilizing its Cell-in-a-Box technology.